www.黄在线看_国产成人午夜精品影院游乐网_国产成人久久av免费高清蜜臀_久久久999久久久_午夜 国产_一区二区三区四区国产

加入收藏 | 設為首頁 | 聯系我們

產品搜索

聯系我們

聯系人:蔣經理
電話:4008750250
號碼:
手機:18066071954
地址:南京市棲霞區緯地路9號
Email: zhangxiangwen@cobioer.com

產品展示 / PRODUCTS
藥靶細胞株 > kinase激酶細胞株 > CBP73001BCR-ABL1/BaF3激酶細胞

BCR-ABL1/BaF3激酶細胞
名稱 BCR-ABL1/BaF3激酶細胞
型號 CBP73001
報價
特點 BCR-ABL1/BaF3激酶細胞,母細胞:BaF3,凍存條件:90% FBS+10% DMSO;
  • 詳細內容

CBP73001

I. Introduction

Cell Line Name:

BCR-ABL1/BaF3

Host Cell:

Ba/F3

Stability:16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)

Application:

Anti-proliferation assay and PD assay

Freeze Medium:

90% FBS+10% DMSO

Complete Culture Medium:

RPMI-1640+10%FBS

Mycoplasma Status:

Negative

II.Background

Presence of a BCR-ABL1 fusion gene is necessary for the pathogenesis of CML. In up to 95% of cases, a t(9;22) (q34;q11) translocation results in the BCR-ABL1 fusion gene (Faderl et al. 1999). This translocation results in the Philadephia chromosome. In rare CML cases lacking the traditional t(9;22) translocation, other translocations result in the creation of the BCR-ABL1 fusion gene, which sometimes involve multiple chromosomes.

ABL1 is a tyrosine kinase, and, in normal cells, it plays a role in cellular differentiation and regulation of the cell cycle. The BCR-ABL1 fusion gene creates a constitutively active tyrosine kinase, which leads to uncontrolled proliferation.

Imatinib is the first-generation ABL tyrosine kinase inhibitor, and it was approved by the FDA in 2001; label indications for CML include use in newly diagnosed adult and pediatric patients and in patients after failure of interferon-alpha therapy. While treatment responses to imatinib are often dramatic and lasting, 30–40% of patients will eventually need further treatment (Santos et al. 2011). In many but not all cases, this is due to the acquisition of point mutations in the tyrosine kinase domain of the BCR-ABL1 fusion gene, which renders the protein insensitive to the inhibitory effect of imatinib. This type of disease progression led to the development of second-line TKIs: dasatinib, nilotinib, and bosutinib. Dasatinib and bosutinib have the additional advantage of being inhibitors of SRC.

The second-generation TKIs, dasatinib, nilotinib, and bosutinib, are more potent than imatinib, and they were developed to treat cases of CML resistant to imatinib. Dasatinib and nilotinib are approved for use in CML in newly diagnosed adults, while dasatinib, nilotinib, and bosutinib are approved for use in adults with resistance or intolerance to prior therapy that included imatinib (FDA 2012). Soverini et al. (2011) made mutation-specific treatment decision recommendations that were adopted by NCCN (2012). Recommendations based on preclinical data are as follows: for T315I, HSCT or clinical trial; for V299L, T315A, and F317L/V/I/C, consider nilotinib rather than dasatinib; for Y253H, E255K/V, and F359V/C/I, consider dasatinib rather than nilotinib; and for all other mutations, consider high-dose imatinib, dasatinib, or nilotinib.

Ponatinib is a third-line TKI, developed specifically to address imatinib resistance due to the BCR-ABL1 T315I resistance mutation. Ponatinib is currently being investigated in phase III clinical trials.


III. Representative Data

1. WB of  BCR-ABL1/BaF3 expression



2. Sanger of BCR-ABL1/BaF3

Figure 2. BCR-ABL1/BaF3 Fusion

3. Anti-proliferation assay

Figure 3. CTG Proliferation Assay of BaF3 BCR-ABL1 WT Cells (C3).



如果你對CBP73001BCR-ABL1/BaF3激酶細胞感興趣,想了解更詳細的產品信息,填寫下表直接與廠家聯系:


留言框

  • 產品:

  • 您的單位:

  • 您的姓名:

  • 聯系電話:

  • 常用郵箱:

  • 省份:

  • 詳細地址:

  • 補充說明:

  • 驗證碼:

    請輸入計算結果(填寫阿拉伯數字),如:三加四=7

化工儀器網

推薦收藏該企業網站
主站蜘蛛池模板: 99热这里只有精品免费国产 | 一级做a爰片久久毛片潮喷 一级做a爰片久久毛片看看 | 国产人成 | 亚洲无线一二三四区手机 | 91久久老司机福利精品网 | 国产日韩精品一区二区在线观看 | 国产自产拍精品视频免费看 | 久久精品成人一区二区三区 | 日产无人区一线二线三线新版 | 国产视频首页 | 国产人成精品 | 国产欧美精品国产国产专区 | 丁香六月狠狠激情综合基地 | 国产成人无码午夜视频在线观看 | 亚洲综合色成在线播放 | 国产精品高清视亚洲精品 | 久久久精品日本一区二区三区 | 亚洲愉拍二区一区三区 | 无码人妻啪啪一区二区 | 欧美一级特黄高清免费 | 免费亚洲视频 | 日本亚洲欧美在线 | 国产午夜影院 | 男人黄女人色视频在线观看 | 国产magnet | 999re6热在线精品视频思思 | 91精品国产一区二区三区左线 | 一区卡二区卡三区卡四区乱码 | 魔术学姐免费版观看 | 美女被视频网站在线看九色 | 国产午夜亚洲精品久久999 | 久久综合爱| 污网址免费 | 五月丁香六月狠狠爱综合 | 国产精品无码专区av在线播放 | 无码人妻精一区二区三区 | 欧美精品一区二区三区四区 | 午夜香蕉成视频人网站高清版 | 精品国产乱码久久久软件下载 | 亚洲熟妇无码av另类vr影视 | 搞黄视频在线观看 |